checkAd

     140  0 Kommentare Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program - Seite 3

    Contacts

    Company:
    Pete De Spain
    Vice President, Investor Relations &
    Corporate Communications
    (858) 500-8803
    pete@kuraoncology.com

    Investors:
    Robert H. Uhl
    Managing Director
    Westwicke ICR
    (858) 356-5932
    robert.uhl@westwicke.com

    Lesen Sie auch

    Media:
    Jason Spark
    Managing Director
    Canale Communications
    (619) 849-6005
    jason@canalecomm.com


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program - Seite 3 – Oral presentation to highlight clinical data for tipifarnib in HRAS mutant solid tumors, including overall survival data in head and neck squamous cell carcinoma –SAN DIEGO, May 13, 2020 (GLOBE NEWSWIRE) - Kura Oncology, Inc. (Nasdaq: KURA), a …